Phuc and colleagues performed a study in which the stem cells of breast cancer CD44+CD24− were isolated from breast tumors; the expression of CD44 was downregulated with siRNAs followed by treatment with specific antitumor concentrations. Here, CD44 is linked to breast carcinoma.